New Cardiac Mapping Options for Complex Arrhythmias

  CARLSBAD, Calif., May 8, 2018 /PRNewswire/ -- Acutus Medical®, a global heart rhythm technology company, today announced that the AcQMap® High Resolution Imaging and Mapping System has been utilized for the first time in U.S. patients. The company also revealed initiation of a new clinical study to evaluate the technology during atrial fibrillation retreatment ablation procedures in Europe and Canada.   "Enabling physicians to see complex, irregular arrhythmias in real-time should provide important new insights and enable truly personalized and individualized ablation therapy planning.  We hope that this unique capability, combined with the ability to quickly re-map after each ablation, will lead the way to further improvements in clinical outcomes for patients suffering from complex arrhythmias," said Vince Burgess, Chairman, President and CEO, at Acutus Medical. "Together with institutions across the country, we hope to transform the lives of people suffering from complex arrhythmias through our innovative technology and are pleased that U.S. patients now have access to AcQMap." The AcQMap System has been used in Europe in 15 centers and in more than 500 procedures. Heart Rhythm Society Meeting Participation Several international presentations featuring the AcQMap System will be presented at the Heart Rhythm Society's 39th Annual Scientific Sessions on May 11 from 9:30 AM EST – 12:00 PM EST in Boston, MA. The company will also be highlighting newl...
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular Imaging Source Type: news